Botulinum toxin treatment of cephalalgia alopecia increases substance P and calcitonin gene-related peptide-containing cutaneous nerves in scalp
FM Cutrer,
P Sandroni,
G Wendelschafer-Crabb,
Corresponding Author
FM Cutrer
Department of Neurology, Mayo Clinic College of Medicine, Rochester and
Dr Michael Cutrer, Department of Neurology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA. Email: [email protected]Search for more papers by this authorP Sandroni
Department of Neurology, Mayo Clinic College of Medicine, Rochester and
Search for more papers by this authorG Wendelschafer-Crabb
University of Minnesota, Minneapolis, MN, USA
Search for more papers by this authorFM Cutrer,
P Sandroni,
G Wendelschafer-Crabb,
Corresponding Author
FM Cutrer
Department of Neurology, Mayo Clinic College of Medicine, Rochester and
Dr Michael Cutrer, Department of Neurology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA. Email: [email protected]Search for more papers by this authorP Sandroni
Department of Neurology, Mayo Clinic College of Medicine, Rochester and
Search for more papers by this authorG Wendelschafer-Crabb
University of Minnesota, Minneapolis, MN, USA
Search for more papers by this author
References
- 1 Cutrer FM, Pittlekow MR. Cephalalgic alopecia areata: a syndrome of neuralgiform head pain and hair loss responsive to Botulinum a toxin injection. Cephalalgia 2006; 26: 492.
- 2 Winkelmann RK. Cutaneous sensory nerves. Sem Dermatol 1988; 7: 236–68.
- 3 Cotsarelis F, Sun TT, Lavker RM. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 1990; 61: 1329–37.
- 4 Bevin S, Szolscanyi J. Sensory neuron-specific actions of capsaicin: mechanism and applications. TIPS 1990; 11: 330–3.
- 5 Paus R, Heinzelmann T, Schultz K-D, Furkert J, Fechner K, Czarnetzki BM. Hair growth induction by Substance P. Lab Invest 1994; 71: 134–40.
- 6 Dimitriadou V, Buzzi MG, Theoharides TC, Moskowitz MA. Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation. Neuroscience 1992; 48: 187–203.
- 7 Nong YH, Titus RG, Ribeiro JM, Remold HG. Peptides encoded by the calcitonin gene inhibit macrophage function. J Immunol 1989; 143: 45–9.
- 8 Wang F, Millet I, Bottomly K, Vignery A. Calcitonin gene-related peptide inhibits interleukin 2 production by murine T lymphocytes. J Biol Chem 1992; 267: 21052–7.
- 9
Kennedy WR,
Wendelschafer-Crabb G,
Polydefkis M,
McArthur J.
Pathology and quantitation of cutaneous nerves. In: PJ Dyck,
PK Thomas, eds.
Peripheral neuropathy, 4th edn. Philadelphia, PA: Saunders
2005; 869–96.
10.1016/B978-0-7216-9491-7.50037-5 Google Scholar
- 10 Siebenhaar F, Sharov AA, Peters EM, Sharova TY, Syska W, Mardaryev AN et al. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata). J Invest Dermatol 2007; 127: 1489–97.
- 11 Peters EM, Liotiri S, Bodó E, Hagen E, Bíró T, Arck PC, Paus R. Probing the effects of stress mediators on the human hair follicle: substance P holds central position. Am J Pathol 2007; 171: 1872–86.
- 12 Levy D, Burstein R, Kainz V, Jakubowski M, Strassman AM. Mast cell degranulation activates a pain pathway underlying migraine headache. Pain 2007; 130: 166–76.
- 13 Durham PL, Cady R, Cady R. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache 2004; 44: 35–43.
- 14 Pareja JA, Cuadrado ML, Feranadez-de-las Penas C, Neito C, Sols M, Pinedo F. Nummular headache with trophic changes inside the painful area. Cephalagia 2008; 28: 186–90.
